Category: Liver cancer

Home / Liver cancer

Categories

Nutritional Advice for Liver Transplant Patients: Pre-and Post-Surgery

Liver TransplantLiver transplantation is a life-saving intervention in patients with end-stage liver disease or acute liver failure. Adequate nutrition is an important component of pre-transplant prep...

The Psychological Impact of Liver Transplantation on Patients and Families

Liver transplantationLiver transplant is a life-saving intervention for patients with end-stage liver disease, acute liver failure, and some genetic disorders. Though the physical and medical aspects ...

Advances in Liver Transplant Surgery: Techniques and Technologies

IntroductionLiver transplant surgery has seen tremendous progress in the last few decades, transforming the therapeutic possibilities of patients with end-stage liver disease, acute liver failure, and...

Liver Transplantation for Alcohol-Related Cirrhosis: Eligibility and Outcomes

IntroductionLiver transplantation is a life-saving intervention for end-stage liver disease patients, including alcohol-related cirrhosis (ALC) patients. Alcohol-related cirrhosis is the result of chr...

The Role of Living Donor Liver Transplants in Addressing Organ Shortages

 IntroductionLiver transplant is a life-saving operation for end-stage liver disease, acute liver failure, or some metabolic disorders. But demand for liver transplantation far outweighs the supply o...

Understanding Post-Liver Transplant Medications: A Comprehensive Guide

 Liver transplantLiver transplantation is a life-threatening surgery for those afflicted by end-stage liver disease, acute liver failure, or certain metabolic conditions. As serious as the operation ...

Melphalan is approved by FDA as a liver-directed treatment for uveal melanoma

Nov 2023: The Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System, Delcath Systems, Inc.) as a liver-directed treatment for adult patients with uveal me...

JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma

SHANGHAI, CHINA, February 28, 2023 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherap...

Tremelimumab is approved by FDA in combination with durvalumab for unresectable hepatocellular carcinoma

November 2022: The Food and Drug Administration approved tremelimumab (Imjudo, AstraZeneca Pharmaceuticals) in combination with durvalumab for adult patients with unresectable hepatocellular carcinoma...

Drugs approved for treatment of liver cancer

Dec 2021: The following drugs are approved as of date for the treatment of liver cancer:. Please check the prescribing information before taking the drug. Atezolizumab Avastin (Bevacizumab) Bevacizum...

We Are Online! Chat With Us!
Scan the code